The DLD-1 colorectal cancer cell line has been shown to express lower levels of SMYD3 than some other colorectal lines [18], which may explain the high dose of Inhibitor-4 (200 μM) needed to reduce the cell viability and proliferation levels by 30 and 50 percent, respectively. This evidence concerns the gene SMYD3 and colorectal cancer.